Amyloidosis
Diagnosis of AL amyloidosis can be challenging, since the symptoms are often very general.
The diagnosis can be confirmed by removing a biopsy (small tissue sample) from the affected part of the body, and examining this under a microscope in the laboratory, using special stainsto check for amyloid proteins.
How the tissue sample is removed will depend on which parts of the body are affected. In some people with suspected anyloidosis, a biopsy of tummy fat (taken using a needle) or a biopsy from the gut (taken during an endoscopy ) may give a positive result.
Further diagnostic tests are also available at the NHS National Amyloidosis Centre at the Royal Free Hospital in London.
These include a type of scan called SAP scintigraphy, which involves being injected with a mildly radioactive version of blood protein before being scanned with a gamma camera.
This protein coats any amyloid deposits in your body, which highlights most areas of the body affected by amyloid deposits.
You may also have further tests to assess how the amyloid deposits have affected your individual organs. For example, an echocardiogram (heart ultrasound scan ) may be carried out to check the condition of your heart.
Amyloidosis is a group of rare but serious conditions caused by deposits of abnormal protein, called amyloid, in tissues and organs throughout the body.
AL amyloidosis can affect any organ, and the symptoms depend on which organs are affected. Most oftenamyloid is deposited in the kidneys and may cause kidney failure. Symptoms of kidney failure can i
AL amyloidosis occurs when an abnormality in the plasma cells found in bone marrow (the spongy tissue at the centre of some bones) results in the excessive production of proteins called 'light chains'
Diagnosis of AL amyloidosis can be challenging, since the symptoms are often very general. The diagnosis can be confirmed by removing a biopsy (small tissue sample) from the affected part of the bod
There are currently no treatments available that can directly remove the amyloid deposits associated with AL amyloidosis. Treatment aims to prevent the further production of abnormal light chains whil
Before effective treatments for AL amyloidosis were discovered, the outlook for the condition was poor, with many people only living for a few months. With modern treatments, the outlook varies depen
If you have amyloidosis, your clinical team will pass information about you on to the National Congenital Anomaly and Rare Diseases Registration Service (NCARDRS). This helps scientists look for bett